Europass Curriculum Vitae

Europass
Curriculum Vitae
Personal information
First name(s) / Surname(s)
Address(es)
Lidia CREMER
103 Splaiul Independentei, sector 5, Bucharest, Romania
Telephone(s)
40 21 3069298; 40 21 5287298
Fax(es)
40 21 3069298; 40 21 5287298
E-mail
Nationality
Date of birth
Gender
Mobile:
40 722851689
[email protected]
Romanian
23.08.1955
Female
Desired employment / Research Fellow / Partner responsible
Occupational field
Work experience
Dates
Occupation or position held
Main activities and responsibilities
2006 - present
Head of Immunomodulation Laboratory
-
Name and address of employer
Dates
Occupation or position held
Main activities and responsibilities
Name and address of employer
Type of business or sector
Page 1/8- Curriculum vitae of
CREMER Lidia
Specific research activities in immunology, immunochemistry, biochemistry, molecular biology
Management and Administration of Immunomnodulation Laboratory; training, directing and
coordination of research activity in the group (researchers, new graduates employees,
technicians).
Writing up scientific proposals and papers
Project director and project responsible in national (CEEX, NUCLEU, PN II, CNCSIS, BIOTECH)
and international projects (co-operations)
Budget authority for acquisition of research equipment, reagents, consumables, services,
participation in scientific meetings etc
“Cantacuzino” National Institute of Research and Development for Microbiology and Immunology
(Cantacuzino NIRDMI), 103 Splaiul Independentei, 050096 Bucharest, Romania
1986 – 2006
Researcher : Junior researcher, Senior researcher (3rd degree, 2nd degree), Immunology Department
- Research on modern strategies approacing the pathogenesis of autoimmune/inflammatory diseases,
by modulating pro and anti-inflammatory cytokine network and using natural/synthetic compounds
- In vivo studies for testing the anti-tumoral capacity (melanoma) of natural/synthetic compounds
- Cytotoxicity/viability tests performed on normal and tumoral cell lines
- Identifying active compounds in modulation of antibody production in vivo
- Identifying the modulatory capacity of some compounds on endotoxic shock induced by LPS
- Identifying and monitoring the activities of compounds with anti-inflammatory and immunosuppressive
properties, which are purified from medicinal plants, by applying cellular and molecular biology tests, in
order to intimate their action and to enlarge their applicability
- Modern methods for testing the efficacy of anti-inflammatory drugs prescribed in the therapy of acute
and chronic inflammatory diseases
- Writing up scientific proposals and papers
“Cantacuzino” National Institute of Research and Development for Microbiology and Immunology, 103
Splaiul Independentei, 050096 Bucharest, Romania
Research and Development. Management: (a) Strategic management, (b) Research activity
management, (c) Research project management.
For more information on Europass go to http://europass.cedefop.europa.eu
© European Communities, 2003 20060628
Dates
Occupation or position held
Main activities and responsibilities
Name and address of employer
Type of business or sector
1979 – 1986
Chemist
Dyes testing
Sintofarm S.A., 22 Ziduri intre Vii, sector 2, 023324 Bucharest, Romania
Industry
Education and training
Dates
Title of qualification awarded
Principal subjects/occupational skills
covered
Name and type of organisation
providing education and training
Dates
Title of qualification awarded
Principal subjects/occupational skills
covered
Name and type of organisation
providing education and training
Dates
Title of qualification awarded
Principal subjects/occupational skills
covered
Name and type of organisation
providing education and training
1992 – 1997
PhD in Medicine
-
Medical Biochemistry
Proinflammatory cytokines and free oxygen radicals: vegetal extracts able to regulate the
synthesis / activity of these mediators of inflammation
“Carol Davila” University of Medicine and Pharmacy, Bucharest
1978 – 1979
Postgraduation training / Research qualification (Master equivalent degree)
Physical Chemistry
University of Bucharest
1974 – 1978
University degree in Chemistry
Chemistry
University of Bucharest, Faculty of Chemistry
Personal skills and
competences
Mother tongue(s)
Other language(s)
Self-assessment
Specify mother tongue Romanian
English, French, Spanish
Understanding
European level (*)
Listening
Reading
Speaking
Spoken interaction
Writing
Spoken production
English Language
French Language
C2
Proficient
C2
Proficient
C2
Proficient
C2
Proficient
C2
Proficient
C2
Proficient
C2
Proficient
C2
Proficient
C2
Proficient
C2
Proficient
Spanish Language
B2 Independent user B2 Independent user A2
Basic
A1
Basic
A1
Basic
Social skills and competences
Page 2/8- Curriculum vitae of
CREMER Lidia
Team work: I have worked in research groups in immunology
Leader work: I am a research group leader since 2006 at “Cantacuzino” NIRDMI
For more information on Europass go to http://europass.cedefop.europa.eu
© European Communities, 2003 20060628
Technical skills and competences
ELISA, immunoblotting, chemiluminometry, fluorimetry, modern colorimetric techniques, cell cultures,
cells isolation and stimulation, in vitro cell cytotoxicity/proliferation techniques, small laboratory
animals immunization methods.
Completed postgraduated courses with diplomas:
 1986 – Basic Immunology Course, Bucharest, Romania
 1988 – IUIS International Immunology Course "The deviated Immune Response", Poiana
Brasov, Romania
 1988 - IUIS International Immunology Course "Regulation of Immunity", Polczyn Zdroj,
Poland
 1990 – NATO/FEBS Summer School "Cellular Regulation by Protein Phosphorylation", La
Londe, France
 1995 - First Balcanic Symposium of FACS users, Varna, Bulgaria
 1996 - EFIS International Immunology Symposium “Signals and Signal Processing in the
Immune System", Tihany, Hungary
 2000 - John Humphrey Course "Self-Tolerance and Self-Recognition", Sinaia, Romania
 2001 - Posgraduate training “From Cellular & Molecular Biology to XXIst century medicine”,
Bucharest, Romania
Other completed training courses with diplomas:
 2006 - Prerequisites of ISO / CEI 17025:2005 - reference for the accreditation of attempt /
calibration laboratories, RENAR
 2007 - Validation of attempt / analysis methods. Practical aspects and computer tools, FiaTest

2007 - Uncertainty measuring evaluation in attempt laboratories. Case studies and
applications, FiaTest
Computer skills and competences
Artistic skills and competences
Driving licence
Microsoft Office (Excel, PowerPoint, Word); MS Outlook; Adobe Photoshop; Internet; etc)
Photography
I hold a driving licence (B category)
Additional information Patents:
 Method for determining double stranded or single stranded anti-DNA antibodies. Authors:
G.Szegli, M.Stefanescu, L.Cremer, V.Enache, Patent No.95732/1988-OSIM (1988)
Member in scientific organizations:
 Member of the Romanian Society for Immunology, since 1987
Nominations:
 2010. Research projects evaluation expert awarded by the Ministry of Research, Bucharest.
Teaching activity:
 Lecturer – Basic Immunology Workshop, organized annually by the Romanian Society for
Immunology (2003 - 2009)
 Long-term expert (Technical expert - Quality management, inter-laboratories comparison) in the
project “Professional and organizational forming of employees in the immunology laboratories, by
initiating efficient technologies and quality management”, financed by the European Social Fund
(Human Resources) POSDRU/81/3.2/S/59497 (2010-2013)
Annex List of published and communicated papers (mainly 2008-2011)
Page 3/8- Curriculum vitae of
CREMER Lidia
For more information on Europass go to http://europass.cedefop.europa.eu
© European Communities, 2003 20060628
Annex
List of published and communicated papers (mainly 2008-2011)
a)
No.
1
2
3
Publications in scientific journals with ISI quotation
Title
Identification of anti-idiotypic antibodies to
anti-phosphotyrosine antibodies in human
sera
Assessment of two synthesized curdlan
derivatives as possible antioxidants and/or
modulators of human PMN cells respiratory
burst
The antioxidant effects of some
progressively purified fractions from
Helleborus purpurascens
b)
No.
Authors
Maria Stefanescu, Cristiana Matache,
A.Onu, C.Cristescu, Lidia Cremer,
G.Szegli
L. Cremer, A-R Lupu, M.M.Badulescu,
G.Mocanu, D.Mihai, A.Calugaru,
N.S.Apetrei, M.Moscovici, G.Szegli
N.S. Apetrei, A-R Lupu, A.Calugaru,
F.Kerek, G.Szegli, L.Cremer
Publications in scientific journals indexed in other international databases
Title
Authors
1
The novel arthritis drug substance MCS-18
attenuates the antibody production in vivo
2
Local analgesic drug “MCS-18” provides
high survival rates in septic-shock mice
F.Kerek, G.Szegli, L.Cremer, A-R
Lupu, S.Durbaca, A.Calugaru,
A.Herold, D.L. Radu
F.Kerek, A.Babes, L.Cremer, A-R
Lupu, C.Coman, A.Calugaru, G.Szegli
3
Effects of cold plasma on B16 and
COLO320 tumoral cells
A-R Lupu, N.Georgescu, A.Calugaru,
L.Cremer, G.Szegli, F.Kerek
4
Recognition and control of Dectin-1
receptors and TLR-2 by Curdlan –like
biopolymers and purified natural extracts
Novel antirheumatic drug “MCS-18” involved
in TLR signaling
A.Calugaru, L.Cremer,
A-R Lupu, M.M. Badulescu,
N.S.Barzu, F.Kerek, G.Szegli
A-R Lupu, L.Cremer, G.Szegli,
A.Calugaru, M.M.Badulescu,
N.S.Barzu, M-L Flonta, F.Kerek
A-R Lupu, L.Cremer, F.Kerek,
A.Calugaru, N.S.Barzu, C.Coman, ML Flonta, G.Szegli
A-R Lupu, L.Cremer, F.Kerek,
A.Calugaru, M.M.Badulescu, M-L
Flonta, G.Szegli
C.C. Surdu-Bob, C.Coman,
A.Calugaru, L.Cremer, M.Badulescu,
E.Vlase
5
6
The role of natural compound D161 in
neurogenic inflammation
7
New natural compound MCS-18, a TLR-2
antagonist
able
to
down-regulate
inflammation-related pain
In vivo and in vitro studies on the efficiency
and toxicity of SBCC implant particles on
B16 melanoma
8
c)
No.
1
Publications in scientific journal with peer-review
Title
Study of apoptosis induced by cytostatics
and vegetal extracts on human endothelial
cell line
Page 4/8- Curriculum vitae of
CREMER Lidia
Authors
N.S.Bârzu, M.M.Bădulescu, A-R Lupu,
L.Cremer , G.Szegli, F.Kerek,
A.Calugaru
Journal
(with ISI quotation)
Autoimmunity, 15, 181-186
(1993)
Romanian Biotechnological
Letters, Vol. 15, No. 6,
5718-5728, (2010)
Romanian Biotechnological
Letters, Vol. 16, No. 6,
6673-6682 (2011)
Journal
(indexed in other
databases)
Acta Microbiologica et
Immunologica Hungarica,
55 (1), 15-31, (2008)
Shock, 29 (Supplement 1),
110, (2008)
Proceeding of 4th
International Congress on
Cold Atmospheric Pressure
Plasmas: Sources and
Applications – CAPPSA
(2009)
European Journal of
Immunology, Vol.39,
No.S1, S77, 2009
European Journal of
Immunology, Vol.39,
No.S1, S77, 2009
European Journal of Pain,
Vol 13, Suppl 1, Sept 2009
European Journal of Pain,
Vol 13, Suppl 1, Sept 2009
Poceedings of The 4th
European Conference for
Clinical Nanomedicine,
The Great Strides towards
the Medicinie of the Future
(2011)
Journal
(with peer-review)
Roum.Arch.Microbiol.Im
munol., Vol.67, Nr.1-2,
pag.5-9 (2008)
For more information on Europass go to http://europass.cedefop.europa.eu
© European Communities, 2003 20060628
2
The modulation of reactive oxygen species
production from human polymorphonuclear
cells by curdlan derivatives as Dectin-1
agonists/antagonists
M.M.Bădulescu, A-R Lupu, L.Cremer,
A.Calugaru, N.S.Apetrei, M.
Moscovici, G.Mocanu, G. Szegli
Roum.Arch.Microbiol.Im
munol., Vol.68, Nr.2,
pag.63-68 (2009)
3
The effects of cold atmospheric plasma jets
on B16 and COLO320 tumoral cells
A-R Lupu, N.Georgescu, A.Calugaru,
L.Cremer, G.Szegli, F.Kerek
4
Recognition and modulation of Dectin-1 and
TLR-2 receptors by curdlan derivatives and
purified natural extracts
5
Curdlan derivatives able to enhance
cytostatic drugs activity on tumoral cells
6
Efectele curdlanului si ale derivatilor sai
asupra sepsisului indus la soareci
7
The effect of some curdlan derivatives on
Dectin-1 expression and cytokine production
in human peripheral blood mononuclear
cells
Implant microparticles – a new concept for
non-invasive cancer therapy
A.Calugaru, L. Cremer,
A-R Lupu, M.M.Badulescu,
N.S.Apetrei, M.Moscovici, G.Mocanu,
D.Mihai, F.Kerek, G.Szegli
M.M.Badulescu, N.S.Apetrei, A-R
Lupu, L.Cremer, G.Szegli,
M.Moscovici, G.Mocanu, D.Mihai,
A.Calugaru
C.Coman, E.Vlase, L.Cremer, A-R
Lupu, N.S.Apetrei, A.Calugaru,
G.Mocanu, D.Mihai, M.Moscovici,
G.Szegli
N.S.Apetrei, A.Calugaru,
M.M.Badulescu, A-R Lupu,
M.Moscovici, G.Mocanu, D.Mihai, G.
Szegli, L.Cremer
C.C. Surdu-Bob, C.Coman,
A.Calugaru, L.Cremer, M.Badulescu,
E.Vlase
N.S.Apetrei, A.Calugaru, F.Kerek,
M.Panteli, I.Rasit, L.Cremer, G.Szegli,
A-R Lupu
Roum.Arch.Microbiol.Im
munol., Vol.68, Nr.3,
pag. 136-144 (2009)
Roum.Arch.Microbiol.Im
munol., Vol.68, Nr.3,
pag.119-124, (2009)
8
9
Cells A highly purified vegetal fraction able
to modulate HMGB1 and to attenuate septic
shock in mice
Roum.Arch.Microbiol.Im
munol., Vol.68, Nr.4,
pag.11-16, (2009)
Revista Romana de
Medicina
Veterinara,
Nr.4, 89-96, (2010)
Roum.Arch.Microbiol.Im
munol., Vol.69, Nr.2,
pag.61-66, (2010)
Roum.Arch.Microbiol.Im
munol., Vol.70, Nr.1,
pag.37-41, (2011)
Roum.Arch.Microbiol.Im
munol., Vol.70, Nr.3,
pag.114-123, (2011)
d)
No.
1
2
3
4
Papers presented in international scientific conferences with program committee
Title
Authors
Scientific conference
(International conference with
program committee)
Analgesic and anti-inflammatory
A-R Lupu, L.Cremer, Sepsis 2008
compound MCS -18 provides high F.Kerek, A.Calugaru,
survival rates in septic-shock mice C.Coman, A.Babes,
G.Szegli
Local analgesic drug “MCS-18”
F.Kerek, A.Babes,
International Shock Congress
provides high survival rates in
L.Cremer,
septic-shock mice
A-R Lupu, C.Coman,
A.Calugaru, G.Szegli
High pressure liquid
B.Burghelea,
Al 31- lea Congres Mondial al Viei
chromatography (HPLC) and
A.Kontek,
si Vinului si a 6-a Adunare
oxygen radical absorbance
R.Campeanu,
Generala a O.I.V.
capacity (ORAC), standardized
G.Caraene,
methods complying with EU
A-R Lupu, R.Porumb,
regulations concerning bioactive
L.Cremer,
products obtained from grape
A.Tudorache
seeds
Pharmacological evaluation of a
B.Burghelea,
International Symposium on New
total grape seed polyphenolic
G.Neagu-Caraene,
Researches in Biotechnology
extract as ingredient in functional
R.Campeanu,
food products complying with EU
L.Cremer,
regulation concerning natural
V.Vulturescu,
bioactive products
G.Radulescu,
C.Nichita,
R.Albulescu,
R.Porumb, A.R.Lupu,
G.Szegli
Page 5/8- Curriculum vitae of
CREMER Lidia
For more information on Europass go to http://europass.cedefop.europa.eu
© European Communities, 2003 20060628
Year, town,
country
19-22 Nov.
2008, Granada,
Spania
28 Iun –
2 Iul 2008
Cologne,
Germania
15-20 Iun 2008,
Verona, Italia
20-21 noiembrie
2008,
Bucuresti
5
Immunosuppressive and antiinflammatory activities of MCS18, a compound isolated from a
total Helleborus purpurascens
extract
6
MCS-18 and D161 – TLR
antagonists or negative regulators
of TLR intracellular signaling?
7
The modulation of free oxygen
radicals production from human
polymorphonuclear cells by
Dectin-1 and TLRs
agonists/antagonists
8
The modulation of IL-10 and TNFalpha released by activated
human PBMC in the presence of
natural and derived beta-glucans
9
Novel antirheumatic drug MCS-18
involved in TLR signaling
10
Recognition and control of Dectin1 receptors and TLR-2 by
Curdlan–like biopolymers and
purified natural extracts
11
The role of natural compound
D161 in neurogenic inflammation
12
New natural compound MCS-18, a
TLR-2 antagonist able to downregulate inflammation-related pain
13
Studies regarding the efficacy of
“Natural SOD” and its fractions on
PMN cells of patients with
rheumatic diseases
14
In vivo and in vitro studies on the
efficiency and toxicity os SBCC
implant particles on B16
melanoma
15
Clinical, histopathological and
immunohistochemical correlation
in ovarian cancer
Page 6/8- Curriculum vitae of
CREMER Lidia
A-R Lupu,
N.Georgescu,
L.Cremer, N.S.Barzu,
M.M.Badulescu,
A.Calugaru,
C.Coman, E.Vlase,
G.Szegli, F.Kerek
A-R Lupu, L.Cremer,
F.Kerek, A.Calugaru,
M.M.Badulescu, M-L
Flonta, G.Szegli
M.M. Badulescu, A-R
Lupu, L.Cremer,
A.Calugaru,
N.S.Barzu,
M.Moscovici,
G.Szegli
N.S.Apetrei,
L.Cremer,
M.M.Badulescu, A-R
Lupu, A.Calugaru,
M.Moscovici,
G.Szegli
A-R Lupu, L.Cremer,
G.Szegli, A.Calugaru,
M.M.Badulescu,
N.S.Barzu,
M-L Flonta, F.Kerek
A.Calugaru,
L.Cremer,
A-R Lupu,
M.M.Badulescu,
N.S.Barzu,
F.Kerek,
G.Szegli
A-R Lupu, L.Cremer,
F.Kerek, A.Calugaru,
N.S.Barzu, C.Coman,
M-L Flonta, G.Szegli
A-R Lupu, L.Cremer,
F.Kerek, A.Calugaru,
M.M.Badulescu, M-L
Flonta, G.Szegli
A-R Lupu, L.Cremer,
A.Herold, M.Cristea,
MM.Badulescu,
N.S.Barzu,
A.Calugaru, G.Szegli
C.C.Surdu-Bob,
C.Coman,
A.Calugaru,
L.Cremer,
M.Badulescu,
E.Vlase
A.Badulescu,
Fl.Badulescu,
C.Popescu,
L.Cremer,
A.Anastasiu
8th EFIS Tatra Immunology
Conference
Iunie 2008,
Strbske Pleso,
Slovacia
TRIPR Conference „Innate
immunity and the pathogenesis of
rheumatic diseases”
6-8 Mai 2009,
Genova, Italia
TRIPR Conference „Innate
immunity and the pathogenesis of
rheumatic diseases”
6-8 Mai 2009,
Genova, Italia
TRIPR Conference „Innate
immunity and the pathogenesis of
rheumatic diseases”
6-8 Mai 2009,
Genova, Italia
The 2nd European Congress of
Immunology
Sept. 2009,
Berlin,
Germania
The 2nd European Congress of
Immunology
Sept. 2009,
Berlin,
Germania
Pain in Europe VI, 6th Congress of
the European Federation of
IASP®, Chapters (EFIC)
Sept. 2009,
Lisabona,
Portugalia
Pain in Europe VI, 6th Congress of
the European Federation of
IASP®, Chapters (EFIC)
Sept. 2009,
Lisabona,
Portugalia
TRIPR Conference „Biological
Agents and Emerging Treatments
in the Management of Rheumatic
Diseases”
27-30 Mai 2010,
Genova, Italia
The 4th European Conference for
Clinical Nanomedicine
23-25 Mai 2011,
Basel, Elvetia
8th Congress of the European
Society of Gynecology
8-11 Sept. 2011,
Copenhaga,
Danemarca
For more information on Europass go to http://europass.cedefop.europa.eu
© European Communities, 2003 20060628
e)
No.
1
2
3
4
5
6
7
8
9
10
11
Communicated papers in national presented in national conferences with program committee
Title
Authors
Scientific conference
Year, town
(National conference with
program committee)
Efectul unor extracte naturale
M.M.Badulescu,
A 38a Conferinta Nationala de
2008, Busteni
asupra producerii de radicali liberi
A-R Lupu, L.Cremer,
Imunologie
de oxigen in celule stimulate la
N.S.Barzu, A.Călugaru,
nivelul receptorilor TLR si Dectin 1 F.Kerek,
M.Moscovici,
G.Szegli
Inhibarea activitatii fosfatidilinozitol N.S.Barzu, L.Cremer,
A 38a Conferinta Nationala de
2008, Busteni
3-kinazei de catre fractiuni
A.Calugaru,
Imunologie
vegetale izolate si purificate din
A-R Lupu,
Helleborus purpurascens
M.M.Badulescu,
F.Kerek, G.Szegli
Activitatile antiinflamatoare ale A-R Lupu, L.Cremer,
Al IV-lea Simpozion “Acad.
26-28 martie
compusilor MCS-18a si MCS-18d N.S.Barzu,
Nicolae Cajal”
2008, Bucuresti
izolati dintr-un extract total de M.M.Badulescu,
Helleborus purpurascens
A.Calugaru, C.Coman,
E.Vlase, G.Szegli,
F.Kerek
Effect of Curdlan type biopolymers A.Calugaru, L.Cremer,
A 39a Conferinta Nationala de
2009,
and some natural extracts on
A-R Lupu,
Imunologie
Calimanesti
Dectin-1 and TLRs
M.M.Badulescu,
N.S.Apetrei,
F.Kerek, G.Szegli
The capacity of some beta-glucan M.MBadulescu,
A 39a Conferinta Nationala de
2009,
biopolymers to modulate reactive
A-R Lupu, L.Cremer,
Imunologie
Calimanesti
oxygen species production from
A.Calugaru, N.S.Barzu,
human polymorphonuclear cells
M.Moscovici,
G.Mocanu, G.Szegli
Cold atmospheric plasma jects – a A-R Lupu,
A 39a Conferinta Nationala de
2009,
new medical device acting on
N.Georgescu,
Imunologie
Calimanesti
tumoral cells
A.Calugaru, L.Cremer,
G.Szegli, F.Kerek
MCS-Ab162 and D161 – possible
A-R Lupu, L.Cremer,
5th „Gheorghe Marinescu”
Oct. 2009,
therapeutic agents in
F.Kerek, A.Calugaru,
Symposium of the National
Bucharest
neuroimmune diseases
C.Coman, E.Vlase,
Neuroscience Society of Romania
M.M.Badulescu,
N.S.Apetrei,
M-L Flonta, G.Szegli
Enhancement of some cytostatic
N.S.Apetrei,
A 40a Conferinta Nationala de
2010, Sibiu
drugs activity on tumor cell lines
M.M.Badulescu,
Imunologie
using curdlan derivatives
L.Cremer,
A-R Lupu, M.Moscovici,
G.Mocanu, D.Mihai,
G.Szegli, A.Calugaru
The modulation of IL-10 and TNF- N.S.Apetrei, L.Cremer,
Conferinta Internationala Anuala
23-25
alpha cytokines activities by highly A.Calugaru,
a SRBBM
Septembrie
purified vegetal extracts and
M.M.Badulescu,
2010, Bucuresti
Curdlan derivatives in human
A-R Lupu,
activated PBMCs
F. Kerek , D.Mihai,
G.Mocanu ,
M.Moscovici, G.Szegli
Preliminary studies on human
A-R Lupu,
The annual International
23-25 sept
PMN cells activation by
T.Popescu,
Conference of the RSBMB
2010, Bucuresti
TiO2−based nanopowders
M.M.Badulescu,
L.Cremer,
L.Diamandescu,
D.Tarabasanu-Mihaila
Inhibition of induced mouse B16
A.Calugaru,
A 40a Conferinta Nationala de
2010, Sibiu
melanoma by metal
C.C Surdu-Bob,
Imunologie
microspherical particles
L.Cremer,
M.Badulescu, C.Coman
Page 7/8- Curriculum vitae of
CREMER Lidia
For more information on Europass go to http://europass.cedefop.europa.eu
© European Communities, 2003 20060628
12
A highly purified fraction from
Helleborus purpurascens able to
modulate HMGB1 release in
human tumor cells and to
attenuate septic shock in mice
13
The antioxidant effects of some
progressively purified vegetal
extracts
Page 8/8- Curriculum vitae of
CREMER Lidia
N.S.Apetrei,
A.Calugaru,
A-R Lupu, M.Panteli ,
I.Rasit,
M.Moscovici, F.Kerek,
G.Szegli, L.Cremer
N.S. Apetrei,
A-R- Lupu, A.Calugaru,
F.Kerek, G.Szegli,
L.Cremer
A 41a Conferinta Anuala de
Imunologie
2011, Timisoara
Conferinta Internationala Anuala
a SRBBM
2011, Craiova
For more information on Europass go to http://europass.cedefop.europa.eu
© European Communities, 2003 20060628